Get our E-Alerts
Articles ▼ All Issues About Us ▼ Submit Manuscript Get our E-Alerts
Perspective, Opinion, Commentary
06 Aug 2025
An Integrative Algorithm for Atopic Dermatitis
Kripa Ahuja, MS, Meghana Sunkara, MS, Peter Lio, MD
Perspective, Opinion, Commentary
25 Mar 2025
An Integrative Algorithm for Atopic Dermatitis
Kripa Ahuja, MS, Meghana Sunkara, MS, Peter Lio, MD
DOI:
10.64550/joid.7fc6hb15
Reviewed by:
Natalie Yin, MD, Steven Daveluy, MD
Abstract

Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin condition affecting individuals of all ages, with a higher prevalence in children. While a range of conventional treatments exist, including topical corticosteroids (TCS), calcineurin inhibitors (TCIs), antibiotics, and immunosuppressants, many patients fail to experience a sufficient improvement in symptoms and quality of life. Additionally, concerns about medication safety have become more prominent on social media, prompting patients and families to explore the realm of complementary and alternative medicine. Tailoring therapy to the individual needs of the patient is crucial, as AD presents differently in each person, and the effectiveness of treatments can vary accordingly. To assist clinicians in navigating these complex options, we provide an example algorithm of an integrative approach, serving as a practical tool to guide clinical decision-making. While by no means exhaustive, it highlights some potential areas for integrating evidence-based complementary treatments that can be considered. By utilizing this comprehensive approach, providers can offer personalized care that meets the diverse needs of their patients while considering a larger universe of therapeutic options.

Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin condition affecting individuals of all ages, with a higher prevalence in children.1–3 Its impact on quality of life (QoL) is profound, as persistent flares contribute to anxiety, depression, sleep disruption, difficulty concentrating, and social isolation.1–3 Although the exact pathogenesis of AD remains unclear, it is recognized as a complex disorder influenced by factors such as skin barrier dysfunction, immune dysregulation, microbiome imbalance, and neuro-behavioral elements.1–3 While a range of conventional treatments exist, including topical corticosteroids (TCS), calcineurin inhibitors (TCIs), antibiotics, and immunosuppressants, many patients fail to experience a sufficient improvement in symptoms and quality of life.1,4 Additionally, concerns about medication safety have become more prominent on social media, prompting patients and families to explore the realm of complementary and alternative medicine.5

Recently the American Academy of Dermatology (AAD) and the American Academy of Allergy, Asthma, and Immunology/American College of Allergy, Asthma, and Immunology Joint Task Force (JTF) have released updated guidelines that focus on topical and systemic treatment of AD.2,3,6 In general, the evidence-based guidelines discuss avoiding exacerbating factors (allergens, triggers, irritants, etc) and encourage regular use of moisturizers.2,3 Regularly established skin care has shown to be efficacious in symptomatic relief of AD.7

Educating patients—particularly within pediatric populations—about the AD disease process and its impact on quality of life can help set more realistic expectations and inform them about the full range of available therapeutic options.8 It is also important to discuss the potential for secondary infectious complications of AD given the increased risk of skin and systemic infections caused by a compromised skin barrier, especially for those who may be hesitant about treatments.9 Therapies such as dilute bleach baths may be helpful in reducing inflammation and strengthening the skin barrier.1,10

Finally, the accuracy of the AD diagnosis should be carefully considered, as AD symptoms—especially in children—can mimic other conditions such as contact dermatitis, scabies, tinea corporis, psoriasis, and in rare cases, more serious conditions such as cutaneous T-cell lymphoma (CTCL) or secondary drug reactions to treatments.11–13

The AAD guidelines recommend using TCS, TCIs, topical PDE-4 inhibitors, and topical janus kinase inhibitors (JAKi) for mild-to-moderate AD, while the JTF guidelines disagree only on the topical JAKi use due to concerns about the boxed warning, highlighting patient fears about conventional medications.2,6 For moderate and severe AD, the guidelines recommends using biologic agents, including dupilumab and tralokinumab, and the JAKi upacitinib and abrocitinib.3 Moreover, systemic therapies such as NB-UVB phototherapy, cyclosporine, and even the use of whole body cryotherapy can be considered for AD that is not responsive to baseline or topical therapy.3,4,14–17 In-patient admission to the hospital or to an eczema day program may be another option for recalcitrant AD, especially in the situation of active flares or infection.18

While many unconventional therapies for AD have been studied and shown to be efficacious, almost all are presented without context, usually as monotherapies. A truly “integrative” approach suggests using such treatments alongside of more conventional ones, and yet the development of practical, standardized integrative guidelines remains an area of ongoing need.1,4,19

Pairing complementary therapies along with conventional ones in an integrative approach may allow for better and broader targeting of the pathogenic components of AD.

For example, botanicals such as sunflower oil, coconut oil, and oatmeal have been identified as effective in supporting the maintenance and restoration of the skin barrier.20–22 Similarly, wet wrap therapy and balneotherapy (therapeutic bathing) have demonstrated comparable benefits, contributing to improved skin hydration and reduced inflammation.23,24 These approaches are particularly appealing to patients seeking non-pharmacological options that align with their preferences for more natural and holistic care.

In addition to topical therapies, oral supplementation has emerged as another critical component of integrative treatment for AD.25–31 L-histidine, hempseed oil, traditional Chinese medicine (TCM) herbs, essential fatty acids (EFA), and vitamin D have shown potential in modulating immune responses and reducing inflammation, providing additional avenues for therapeutic intervention.25–31 Vitamin E also has anti-inflammatory and antioxidant properties.32 Studies have demonstrated that in patients with AD who were administered 400 IU of vitamin E daily for 4 months, the patients experienced greater improvement in their symptoms compared with those patients taking placebo in terms of reducing itching, severity of atopic dermatitis score (SCORAD), and extent of lesion which was characterized by erythema, edema, excoriation, and lichenification.32

Additionally, probiotics have demonstrated substantial benefits in patients with AD, although the overall body of evidence remains somewhat inconsistent.33,34 They may decrease epithelial permeability to pathogens and their products with the end result of decreased inflammation leading to measurable changes in the SCORAD for patients with AD who take probiotic mixtures.35

Other topical treatments have advantages as well. Black tea compresses have demonstrated a significant decrease in eczema severity and itch.36 Although incompletely understood, black tea is known to contain astringents such as tannins and flavonoids that possess anti-inflammatory properties.36 Vitamin B12 cream has also demonstrated meaningful efficacy in treating AD across multiple ages and appears safe, without any significant side effects.37,38 Similarly, indigo naturalis, formulated as a cream, was found to decrease eczema severity significantly compared to vehicle control.39

In addition to topical and oral therapies, behavioral interventions have shown promise in managing AD.1,4,19 Habit reversal therapy, a behavioral technique that encourages performing another action when having the urge to scratch has shown impressive results in patients with AD.1 Techniques such as nightly massage therapy, relaxation exercises, meditation, and hypnotherapy can help alleviate stress, which is often a significant trigger for AD flares.1,4,19 These therapies promote overall well-being by reducing anxiety and improving sleep, which can directly impact skin health.1,4,19 Acupuncture, an ancient practice rooted in TCM, has also been explored as a complementary approach for AD, with studies suggesting that it may help modulate immune responses and reduce inflammation.1,4,19 Incorporating these behavioral interventions into a comprehensive treatment plan can offer patients a holistic approach to managing AD, enhancing both physical and mental health.

Tailoring therapy to the individual needs of each patient is crucial, as AD presents differently in every person, and the effectiveness of integrative treatments can vary accordingly. An important caveat is that AD affects patients of all ages. While some evidence exists for each intervention described—just as with conventional medications—the majority of studies have been conducted in adults. Clinicians must therefore be particularly cautious when treating children and infants, as some approaches may not be suitable for pediatric patients. To help navigate these complex options, Figure 1 presents an integrative treatment algorithm as a practical tool for clinical decision-making. While by no means exhaustive, it highlights key areas where evidence-based complementary treatments can be integrated. By adopting this comprehensive approach, providers can offer personalized care that addresses the diverse needs of their patients while expanding the range of therapeutic options available.

Figure 1.

Figure 1.

Description: Integrative Treatment Algorithm for Atopic Dermatitis.

Disclosures and Conflicts of Interest

Kripa Ahuja and Meghana Sunkara have no disclosures or conflicts of interest. Dr. Lio reports research grants/funding from AbbVie, AOBiome; is on the speaker’s bureau for AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oréal, MyOR Diagnostics, ParentMD, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica; reports consulting/advisory boards for Alphyn, AbbVie, Almirall, Amyris, Arcutis, ASLAN, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Janssen, Johnson & Johnson, Kimberly-Clark, LEO Pharma, Lipidor, L’Oréal, Merck, Micreos, MyOR Diagnostics, Regeneron/Sanofi Genzyme, Skinfix, Theraplex, UCB, Unilever, Verrica Yobee Care; stock options with Codex, Concerto Biosciences and Yobee Care. In addition, Dr. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member of the National Eczema Association.

Funding

No funding sources were secured for this study.

References
1. A Multidisciplinary Toolbox for Atopic Dermatitis Treatments. Accessed August 30, 2024. https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/
2. Sidbury R., Alikhan A., Bercovitch L... "Guidelines of care for the management of atopic dermatitis in adults with topical therapies." J Am Acad Dermatol, vol. 89, 2023, p. e1. DOI: 10.1016/j.jaad.2022.12.029.
Google Scholar
3. Davis D. M. R., Drucker A. M., Alikhan A... "Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies." J Am Acad Dermatol, vol. 90, 2024, p. e43. DOI: 10.1016/j.jaad.2023.08.102.
Google Scholar
4. Vieira B. L., Lim N. R., Lohman M. E., Lio P. A.. "Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review." Am J Clin Dermatol, vol. 17, 2016, p. 557. DOI: 10.1007/s40257-016-0209-1.
Google Scholar
5. Ahuja K., DeSena G., Lio P. A.. "A response to “Steroid phobia on social media platforms.”." Pediatr Dermatol, vol. 40, 2023, p. 968. DOI: 10.1111/pde.15373.
Google Scholar
6. Chu D.K., Schneider L., Asiniwasis R.N... "Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations." Ann Allergy Asthma Immunol, vol. 132, 2024, p. 274. DOI: 10.1016/j.anai.2023.11.009.
Google Scholar
7. Mayba J. N., Gooderham M. J.. "A Guide to Topical Vehicle Formulations." J Cutan Med Surg, vol. 22, 2018, p. 207. DOI: 10.1177/1203475417743234.
Google Scholar
8. Takaoka R., Aoki V.. "Education of Patients with Atopic Dermatitis and Their Caregivers." Pediatr Allergy Immunol Pulmonol, vol. 29, 2016, p. 160. DOI: 10.1089/ped.2016.0702.
Google Scholar
9. Wang V., Boguniewicz J., Boguniewicz M., Ong P.Y.. "The infectious complications of atopic dermatitis." Ann Allergy Asthma Immunol, vol. 126, 2021, p. 3. DOI: 10.1016/j.anai.2020.08.002.
Google Scholar
10. Huang J. T., Abrams M., Tlougan B., Rademaker A., Paller A. S.. "Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity." Pediatrics, vol. 123, 2009, p. e808. DOI: 10.1542/peds.2008-2217.
Google Scholar
11. Li Y., Li L.. "Contact Dermatitis: Classifications and Management." Clin Rev Allergy Immunol, vol. 61, 2021, p. 245. DOI: 10.1007/s12016-021-08875-0.
Google Scholar
12. Boesjes C. M., Van Der Gang L. F., Bakker D. S... "Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis." JAMA Dermatol, vol. 159, 2023, p. 1240. DOI: 10.1001/jamadermatol.2023.3849.
Google Scholar
13. Krol A., Krafchik B.. "The differential diagnosis of atopic dermatitis in childhood." Dermatol Ther, vol. 19, 2006, p. 73. DOI: 10.1111/j.1529-8019.2006.00058.x.
Google Scholar
14. Lee S.S., Tan A.W.H., Giam Y.C.. "Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study." Ann Acad Med Singapore, vol. 33, 2004, p. 311. DOI: 10.47102/annals-acadmedsg.V33N3p311.
Google Scholar
15. Goujon C., Viguier M., Staumont-Sallé D... "Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial." J Allergy Clin Immunol Pract, vol. 6, 2018, p. 562. DOI: 10.1016/j.jaip.2017.07.007.
Google Scholar
16. Klimenko T., Ahvenainen S., Karvonen S. L.. "Whole-Body Cryotherapy in Atopic Dermatitis." Arch Dermatol, vol. 144, 2008, p. . DOI: 10.1001/archderm.144.6.806.
Google Scholar
17. Dayal S., Pathak K., Sahu P., Jain V.K.. "Narrowband UV-B phototherapy in childhood atopic dermatitis: efficacy and safety." An Bras Dermatol, vol. 92, 2017, p. 801. DOI: 10.1590/abd1806-4841.20175958.
Google Scholar
18. Cathcart S., Theos A.. "Inpatient management of atopic dermatitis: Inpatient management of atopic dermatitis." Dermatol Ther, vol. 24, 2011, p. 249. DOI: 10.1111/j.1529-8019.2011.01400.x.
Google Scholar
19. Shi K., Lio P. A.. "Alternative Treatments for Atopic Dermatitis: An Update." Am J Clin Dermatol, vol. 20, 2019, p. 251. DOI: 10.1007/s40257-018-0412-3.
Google Scholar
20. Eichenfield L. F., McCollum A., Msika P.. "The Benefits of Sunflower Oleodistillate (SOD) in Pediatric Dermatology." Pediatr Dermatol, vol. 26, 2009, p. 669. DOI: 10.1111/j.1525-1470.2009.01042.x.
Google Scholar
21. Verallo-Rowell V. M., Dillague K. M., Syah-Tjundawan B. S.. "Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis." Dermat Contact Atopic Occup Drug, vol. 19, 2008, p. 308. DOI: 10.2310/6620.2008.08052.
Google Scholar
22. Lisante T. A., Nunez C., Zhang P., Mathes B. M.. "A 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies." J Drugs Dermatol JDD, vol. 16, 2017, p. 671. DOI: .
23. Lee J., Lee S., Kim D., Bang D.. "The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis." J Eur Acad Dermatol Venereol, vol. 21, 2007, p. 1360. DOI: 10.1111/j.1468-3083.2007.02277.x.
Google Scholar
24. Matz H., Orion E., Wolf R.. "Balneotherapy in dermatology." Dermatol Ther, vol. 16, 2003, p. 132. DOI: 10.1046/j.1529-8019.2003.01622.x.
Google Scholar
25. Tan S.P., Brown S.B., Griffiths C.E., Weller R.B., Gibbs N.K.. "Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis." Clin Cosmet Investig Dermatol, vol. 10, 2017, p. 403. DOI: 10.2147/CCID.S146760.
Google Scholar
26. Tan H. Y., Zhang A. L., Chen D., Xue C. C., Lenon G. B.. "Chinese herbal medicine for atopic dermatitis: A systematic review." J Am Acad Dermatol, vol. 69, 2013, p. 295. DOI: 10.1016/j.jaad.2013.01.019.
Google Scholar
27. Schalin-Karrila M., Mattila L., Jansen C. T., Uotila P.. "Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins." Br J Dermatol, vol. 117, 1987, p. 11. DOI: 10.1111/j.1365-2133.1987.tb04085.x.
Google Scholar
28. Koch C., Dölle S., Metzger M... "Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial." Br J Dermatol, vol. 158, 2008, p. 786. DOI: 10.1111/j.1365-2133.2007.08430.x.
Google Scholar
29. Callaway J., Schwab U., Harvima I... "Efficacy of dietary hempseed oil in patients with atopic dermatitis." J Dermatol Treat, vol. 16, 2005, p. 87. DOI: 10.1080/09546630510035832.
Google Scholar
30. Sharma S.. "Correlation of Vitamin D3 Levels and SCORAD Index in Atopic Dermatits: A Case Control Study." J Clin Diagn Res, vol. , 2017, p. . DOI: 10.7860/JCDR/2017/27188.10223.
Google Scholar
31. Camargo C. A., Ganmaa D., Sidbury R., Erdenedelger K. h., Radnaakhand N., Khandsuren B.. "Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children." J Allergy Clin Immunol, vol. 134, 2014, p. 831. DOI: 10.1016/j.jaci.2014.08.002.
Google Scholar
32. Jaffary F., Faghihi G., Mokhtarian A., Hosseini S.M.. "Effects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial." J Res Med Sci Off J Isfahan Univ Med Sci, vol. 20, 2015, p. 1053. DOI: 10.4103/1735-1995.172815.
Google Scholar
33. Anania C., Brindisi G., Martinelli I... "Probiotics Function in Preventing Atopic Dermatitis in Children." Int J Mol Sci, vol. 23, 2022, p. 5409. DOI: 10.3390/ijms23105409.
Google Scholar
34. Yoon W., Park S.H., Lee J.S... "Probiotic mixture reduces gut inflammation and microbial dysbiosis in children with atopic dermatitis." Australas J Dermatol, vol. 62, 2021, p. . DOI: 10.1111/ajd.13644.
Google Scholar
35. Wang I.-J., Wang J.-Y.. "Children with atopic dermatitis show clinical improvement after Lactobacillus exposure." Clin Exp Allergy, vol. 45, 2015, p. 779. DOI: 10.1111/cea.12489.
Google Scholar
36. Witte M., Krause L., Zillikens D., Shimanovich I.. "Black tea dressings – a rapidly effective treatment for facial dermatitis." J Dermatol Treat, vol. 30, 2019, p. 785. DOI: 10.1080/09546634.2019.1573306.
Google Scholar
37. Januchowski R.. "Evaluation of Topical Vitamin B 12 for the Treatment of Childhood Eczema." J Altern Complement Med, vol. 15, 2009, p. 387. DOI: 10.1089/acm.2008.0497.
Google Scholar
38. Stucker M., Pieck C., Stoerb C., Niedner R., Hartung J., Altmeyer P.. "Topical vitamin B12-a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial." Br J Dermatol, vol. 150, 2004, p. 977. DOI: 10.1111/j.1365-2133.2004.05866.x.
Google Scholar
39. Lin Y. K., Chang S. H., Yang C. Y., See L. C., Lee B. H., Shih I. H.. "Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial." J Ethnopharmacol, vol. 250, 2020, p. 112477. DOI: 10.1016/j.jep.2019.112477.
Google Scholar
28
Downloads
177
Total Views
Article impact
Share
Cite
Article Info
DOI:
10.64550/joid.7fc6hb15
Reviewed by:
Natalie Yin, MD, Steven Daveluy, MD
View PDF
Citation
Cite as
[1]
“An Integrative Algorithm for Atopic Dermatitis: Following this algorithm, providers can expertly integrate integrative therapies into atopic dermatitis treatment plans, including topicals and systemics, while adjusting therapy based on patient outcomes for optimal care”., JOID, vol. 1, no. 1, Mar. 2025, doi: 10.64550/joid.7fc6hb15.
Export citation
Select the format you want to export the citation of this publication.
Download Citation
Export Citation